Varaico: Literature-Extracted Genetic Variants

Gene:RET
Variant:p.K758M
Back to variants list

RET

NM_020975.6:p.K758M

Associated Papers

CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche.

Qiu T et al.

Proceedings of the National Academy of Sciences of the United States of America, 2024

An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function.

Cuesta-Hernández HN et al.

Nature Communications, 2023

TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.

Guo Q et al.

Cell Reports, 2023

Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability.

Shehata MA et al.

Journal of Advanced Research, 2023

Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis.

Tabata J et al.

Cancer Research, 2022

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions.

Estrada-Zuniga CM et al.

Cell Reports. Medicine, 2022

35858593 (PubMed )
Supplement: mmc1.pdf

RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma.

Moodley S et al.

Lung Cancer (amsterdam, Netherlands), 2020

GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion.

Crupi MJF et al.

Oncogene, 2020

A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis.

Azad T et al.

Oncogene, 2020

ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.

Luo J et al.

Theranostics, 2019

RET rearrangements are actionable alterations in breast cancer.

Paratala BS et al.

Nature Communications, 2018

Pathogenic Germline Variants in 10,389 Adult Cancers.

Huang KL et al.

Cell, 2018

Structure and function of RET in multiple endocrine neoplasia type 2.

Plaza-Menacho I

Endocrine-related Cancer, 2018

Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.

Gudernova I et al.

Oncotarget, 2017

Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.

Hyndman BD et al.

Journal of Cell Science, 2017

Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.

Wills MK et al.

The Journal of Biological Chemistry, 2017

RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.

Plaza-Menacho I et al.

Cell Reports, 2016

Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.

Crupi MJ et al.

Traffic (copenhagen, Denmark), 2015

A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.

Bagheri-Yarmand R et al.

The Journal of Biological Chemistry, 2015

Mechanisms of RET signaling in cancer: current and future implications for targeted therapy.

Plaza-Menacho I et al.

Cellular Signalling, 2014

Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.

Plaza-Menacho I et al.

Molecular Cell, 2014

Multiple functional effects of RET kinase domain sequence variants in Hirschsprung disease.

Hyndman BD et al.

Human Mutation, 2013

Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations.

Chatterjee R et al.

Human Genetics, 2012

Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.

Plaza-Menacho I et al.

The Journal of Biological Chemistry, 2011

Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.

Perrinjaquet M et al.

The Journal of Biological Chemistry, 2010

Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.

Richardson DS et al.

Cancer Research, 2009

XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.

Lodyga M et al.

Oncogene, 2009

RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec.

Yang Y et al.

Human Mutation, 2008

A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.

Gujral TS et al.

Cancer Research, 2008

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B.

Gujral TS et al.

Cancer Research, 2006

17108110 (PubMed )
Supplement: 00085472can063329-sup-suplementary_figure_6.pdf

RET ligand-induced internalization and its consequences for downstream signaling.

Richardson DS et al.

Oncogene, 2006

Interaction of SH2-Bbeta with RET is involved in signaling of GDNF-induced neurite outgrowth.

Zhang Y et al.

Journal of Cell Science, 2006

Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.

Scott RP et al.

The Journal of Biological Chemistry, 2005

Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis.

Jain S et al.

Development (cambridge, England), 2004

Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth.

Crowder RJ et al.

The Journal of Biological Chemistry, 2004

Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival.

Encinas M et al.

The Journal of Biological Chemistry, 2004

Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.

Castellone MD et al.

Oncogene, 2004

RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.

Kim DW et al.

Molecular Endocrinology (baltimore, Md.), 2003

Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.

Castellone MD et al.

Oncogene, 2003

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.

Grimm J et al.

The Journal of Cell Biology, 2001

1–50 of 53 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."